Showing results (201-210 of 222) with videos related to
Sort By:
Pageof 23
Oncology Letters|August 13, 2020
Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4Bl in MCF-7 breast cancer cellsLuciana Amaral de Mascena Costa, Dipti Debnath, Ashlyn C Harmon, et al.BMC Cancer|November 7, 2014
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapyEdwin Choy, James E Butrynski, David C Harmon, et al.Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.Annals of Surgical Oncology|March 5, 2009
Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomasUgwuji N Maduekwe, Francis J Hornicek, Dempsey S Springfield, et al.Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.Journal of Surgical Oncology|April 23, 2014
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomasThomas F DeLaney, Norbert J Liebsch, Frank X Pedlow, et al.Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.Plant Physiology|June 14, 2003
The Arabidopsis CDPK-SnRK superfamily of protein kinasesEstelle M Hrabak, Catherine W M Chan, Michael Gribskov, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)H J M Groen, M A Socinski, F Grossi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]Robert G Maki, J Kyle Wathen, Shreyaskumar R Patel, et al.Pageof 23